NL8601519A - Furosemidezouten. - Google Patents

Furosemidezouten. Download PDF

Info

Publication number
NL8601519A
NL8601519A NL8601519A NL8601519A NL8601519A NL 8601519 A NL8601519 A NL 8601519A NL 8601519 A NL8601519 A NL 8601519A NL 8601519 A NL8601519 A NL 8601519A NL 8601519 A NL8601519 A NL 8601519A
Authority
NL
Netherlands
Prior art keywords
furosemide
quaternary ammonium
choline
compounds
reaction component
Prior art date
Application number
NL8601519A
Other languages
English (en)
Dutch (nl)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NL8601519A publication Critical patent/NL8601519A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
NL8601519A 1985-07-02 1986-06-11 Furosemidezouten. NL8601519A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/751,763 US4663348A (en) 1985-07-02 1985-07-02 Furosemide salts and pharmaceutical preparations thereof
US75176385 1985-07-02

Publications (1)

Publication Number Publication Date
NL8601519A true NL8601519A (nl) 1987-02-02

Family

ID=25023379

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8601519A NL8601519A (nl) 1985-07-02 1986-06-11 Furosemidezouten.

Country Status (14)

Country Link
US (1) US4663348A (cg-RX-API-DMAC7.html)
JP (1) JPS625975A (cg-RX-API-DMAC7.html)
AU (1) AU599034B2 (cg-RX-API-DMAC7.html)
BE (1) BE904986A (cg-RX-API-DMAC7.html)
CH (1) CH670448A5 (cg-RX-API-DMAC7.html)
DE (1) DE3619665A1 (cg-RX-API-DMAC7.html)
DK (1) DK312586A (cg-RX-API-DMAC7.html)
FR (1) FR2584405B1 (cg-RX-API-DMAC7.html)
GB (1) GB2189239B (cg-RX-API-DMAC7.html)
IT (1) IT1191972B (cg-RX-API-DMAC7.html)
LU (1) LU86484A1 (cg-RX-API-DMAC7.html)
NL (1) NL8601519A (cg-RX-API-DMAC7.html)
SE (1) SE8602917L (cg-RX-API-DMAC7.html)
ZA (1) ZA864207B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920145A (en) * 1988-02-29 1990-04-24 Gaf Chemical Corporation Water-soluble complexes of water-insoluble pharmaceutical compounds and preparation thereof
IT1237115B (it) * 1989-10-24 1993-05-18 Sali della furosemide, procedimento per la loro preparazione e composizionni farmaceutiche che li contengono
US5330280A (en) * 1991-12-03 1994-07-19 Kokuyo Kabushiki Kaisha Filing apparatus of both-side opening/closing type
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
FI114538B (fi) * 2001-01-12 2004-11-15 Finnfeeds Finland Ltd Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
RU2416404C1 (ru) * 2009-10-05 2011-04-20 Государственное образовательное учреждение высшего профессионального образования "Алтайский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Средство, обладающее мочегонным действием
BR112012020110B1 (pt) 2010-02-10 2021-06-08 Kissei Pharmaceutical Co., Ltd. composto derivado heterocíclico fusionado, composição farmacêutica que compreende o mesmo e uso terapêutico do dito composto
CN105431145B (zh) 2013-04-05 2019-12-10 Sc医药品有限公司 用于呋塞米的皮下施用的药物制剂
WO2020120482A1 (en) 2018-12-10 2020-06-18 Sq Innovation Ag Pharmaceutical compositions of furosemide and uses thereof
EP3906020B1 (en) 2019-01-04 2025-12-31 SQ Innovation AG Pharmaceutical compositions of torsemide and their uses
CN113271923B (zh) 2019-01-04 2025-05-13 Sq创新股份公司 呋塞米的药物组合物及其用途
CA3128033A1 (en) 2019-01-31 2020-08-06 Scpharmaceuticals Inc. Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3565920A (en) * 1966-12-29 1971-02-23 Ciba Geigy Corp 5-sulfamyl-anthranilic acids
DK138322B (da) * 1970-07-13 1978-08-14 Dumex Ltd As Fremgangsmåde til fremstilling af N-substituered antranilsyrederivater.
FR2210607A1 (en) * 1972-12-20 1974-07-12 Aries Robert 4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid prepn. - from furfural and 4-chloro-5-sulphamoyl anthranilic acid
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets
LU74319A1 (cg-RX-API-DMAC7.html) * 1976-02-09 1977-08-19
DE3025367A1 (de) * 1980-07-04 1982-01-28 Hoechst Ag, 6000 Frankfurt Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung

Also Published As

Publication number Publication date
FR2584405A1 (fr) 1987-01-09
DK312586D0 (da) 1986-07-01
IT8648183A0 (it) 1986-06-25
BE904986A (fr) 1986-12-24
DK312586A (da) 1987-01-03
LU86484A1 (fr) 1986-12-02
GB2189239A (en) 1987-10-21
DE3619665A1 (de) 1987-01-08
AU5889086A (en) 1987-01-08
CH670448A5 (cg-RX-API-DMAC7.html) 1989-06-15
SE8602917D0 (sv) 1986-07-01
GB8615275D0 (en) 1986-07-30
GB2189239B (en) 1989-02-01
AU599034B2 (en) 1990-07-12
ZA864207B (en) 1987-02-25
US4663348A (en) 1987-05-05
IT8648183A1 (it) 1987-12-25
JPS625975A (ja) 1987-01-12
FR2584405B1 (fr) 1989-02-24
SE8602917L (sv) 1987-01-03
IT1191972B (it) 1988-03-31

Similar Documents

Publication Publication Date Title
NL8601519A (nl) Furosemidezouten.
CN103221414B (zh) 苯并二氮杂*衍生物的托西酸盐及其多晶型、它们的制备方法和用途
US4849425A (en) Readily absorbable pharmaceutical composition
JPS6191116A (ja) 安定化された注射用ピロキシカム液剤
SU1514240A3 (ru) СПОСОБ ПОЛУЧЕНИЯ СТАБИЛЬНЫХ ЦИКЛОДЕКСТРИН-РОМАШКОВЫХ КОМПЛЕКСОВ, включения
JPH0460987B2 (cg-RX-API-DMAC7.html)
JPH0419996B2 (cg-RX-API-DMAC7.html)
KR900006722B1 (ko) 항불안제
KR840000702B1 (ko) 빈카민 사카리네이트의 제조방법
US4698361A (en) Tris-chydroxymethyl) aminomethane salt of 4-chloro-N-furfuryl-5-sulfamoyl anthranilic acid and diuretic compositions containing the same
JP3076672B2 (ja) キノリン誘導体のフマル酸塩
EP0040422B1 (en) Novel substituted pyrazinyl-1,2,4-oxadiazoles, processes for preparing the same and a pharmaceutical composition containing the same
CA1065865A (en) Piperazinyluracil salt
JPH10507446A (ja) ビス−２−アミノピリジン類、その製造方法及び寄生虫感染を制御するためのその用途
KR850000210B1 (ko) 옥사졸린의 제조방법
PL138044B1 (en) Method of obtaining salts of ethylenediamine,ethanolamine or diethanolamine and n-/2-pyridil/-2-methyl-4-hydroxy-2h-1,2-benzothiazinocraboxyamide-3 1,1-dioxide
US4329355A (en) Mesoionic antitumor compositions and methods for using the same in the treatment of cancer
JPH0370700B2 (cg-RX-API-DMAC7.html)
US4218465A (en) Glyoxylic acid hydrocarbylsulfonylhydrazones and therapeutic compositions
KR100256078B1 (ko) 2-아미노에탄술폰산 아연 착체(錯體)
CA1254569A (en) Sulfonic acid salts of 6-amino-1,5-dihydro-4h- imidazo¬4,5-c|pyridin-4-one
WO2005023803A1 (en) Phosphoric acid salt of 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl] methyl]- 2,4-thiazolidinedione
JPH0340038B2 (cg-RX-API-DMAC7.html)
US4761478A (en) 3-deazaguanine sulfonic acid salts
JPS5936696A (ja) ２′―デオキシ―５―置換ウリジン誘導体及びそれを含有する抗腫瘍剤